Matthew Philip Goetz, MD

  • 9062 Citations
  • 45 Scopus h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis

Reese, J. M., Bruinsma, E. S., Nelson, A. W., Chernukhin, I., Carroll, J. S., Li, Y., Subramaniam, M., Suman, V. J., Negron, V., Monroe, D. G., Ingle, J. N., Goetz, M. P. & Hawse, J. R., Oct 9 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 41, p. E9580-E9589

Research output: Contribution to journalArticle

8 Scopus citations

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Yu, J., Qin, B., Moyer, A. M., Sinnwell, J. P., Thompson, K. J., Copland, J. A., Marlow, L. A., Miller, J. L., Yin, P., Gao, B., Minter-Dykhouse, K., Tang, X., McLaughlin, S. A., Moreno-Aspitia, A., Schweitzer, A., Lu, Y., Hubbard, J., Northfelt, D. W., Gray, R. J., Hunt, K. & 10 others, Conners, A. L., Suman, V. J., Kalari, K. R., Ingle, J. N., Lou, Z., Visscher, D. W., Weinshilboum, R., Boughey, J. C., Goetz, M. P. & Wang, L., Dec 6 2017, In : Breast cancer research : BCR. 19, 1, 1 p.

Research output: Contribution to journalArticle

17 Scopus citations

Estrogen, SNP-dependent chemokine expression and selective estrogen receptor modulator regulation

Ho, M. F., Bongartz, T., Liu, M., Kalari, K. R., Goss, P. E., Shepherd, L. E., Goetz, M. P., Kubo, M., Ingle, J. N., Wang, L. & Weinshilboum, R. M., Mar 2016, In : Molecular Endocrinology. 30, 3, p. 382-398 17 p.

Research output: Contribution to journalArticle

17 Scopus citations

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

Wu, X., Subramaniam, M., Grygo, S. B., Sun, Z., Negron, V., Lingle, W. L., Goetz, M. P., Ingle, J. N., Spelsberg, T. C. & Hawse, J. R., Mar 10 2011, In : Breast Cancer Research. 13, 2, R27.

Research output: Contribution to journalArticle

47 Scopus citations

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

Ingle, J. N., Kalari, K. R., Buzdar, A. U., Robson, M. E., Goetz, M. P., Desta, Z., Barman, P., Dudenkov, T. T., Northfelt, D. W., Perez, E. A., Flockhart, D. A., Williard, C. V., Wang, L. M. & Weinshilboum, R. M., May 1 2014, (Accepted/In press) In : Steroids.

Research output: Contribution to journalArticle

25 Scopus citations

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: Results from the NSABP P1 and P2 clinical trials

Goetz, M. P., Schaid, D. J., Wickerham, D. L., Safgren, S., Mushiroda, T., Kubo, M., Batzler, A., Costantino, J. P., Vogel, V. G., Paik, S., Carlson, E. E., Flockhart, D. A., Wolmark, N., Nakamura, Y., Weinshilboum, R. M., Ingle, J. N. & Ames, M. M., Nov 1 2011, In : Clinical Cancer Research. 17, 21, p. 6944-6951 8 p.

Research output: Contribution to journalArticle

37 Scopus citations

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

Safgren, S. L., Suman, V. J., Kosel, M. L., Gilbert, J. A., Buhrow, S. A., Black, J. L., Northfelt, D. W., Modak, A. S., Rosen, D., Ingle, J. N., Ames, M. M., Reid, J. M. & Goetz, M. P., Mar 27 2015, In : Pharmacogenetics and genomics. 25, 4, p. 157-163 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer

Yadav, S., Hu, C., Hart, S. N., Boddicker, N., Polley, E. C., Na, J., Gnanaolivu, R., Lee, K. Y., Lindstrom, T., Armasu, S., Fitz-Gibbon, P., Ghosh, K., Stan, D. L., Pruthi, S., Neal, L., Sandhu, N. P., Rhodes, D. J., Klassen, C., Peethambaram, P. P., Haddad, T. C. & 7 others, Olson, J. E., Hoskin, T. L., Goetz, M. P., Domchek, S. M., Boughey, J. C., Ruddy, K. J. & Couch, F. J., May 1 2020, In : Journal of Clinical Oncology. 38, 13, p. 1409-1418 10 p.

Research output: Contribution to journalArticle

Open Access

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Ellingson, M. S., Hart, S. N., Kalari, K. R., Suman, V., Schahl, K. A., Dockter, T. J., Felten, S. J., Sinnwell, J. P., Thompson, K. J., Tang, X., Vedell, P. T., Barman, P., Sicotte, H., Eckel-Passow, J. E., Northfelt, D. W., Gray, R. J., McLaughlin, S. A., Moreno-Aspitia, A., Ingle, J. N., Moyer, A. M. & 9 others, Visscher, D. W., Jones, K., Conners, A., McDonough, M., Wieben, E. D., Wang, L., Weinshilboum, R., Boughey, J. C. & Goetz, M. P., Sep 7 2015, In : Breast Cancer Research and Treatment. 153, 2, p. 435-443 9 p.

Research output: Contribution to journalArticle

12 Scopus citations

Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study

Nguyen, T. T., Hoskin, T. L., Day, C. N., Habermann, E. B., Goetz, M. P. & Boughey, J. C., Aug 1 2017, (Accepted/In press) In : Annals of Surgical Oncology. p. 1-10 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

First-in-human phase I Study of the tamoxifen metabolite Z-endoxifen in women with endocrine-refractory metastatic breast cancer

Goetz, M. P., Suman, V. J., Reid, J. M., Northfelt, D. W., Mahr, M. A., Ralya, A. T., Kuffel, M., Visscher, S. A., Kipp, B. R., Liu, M. C., Hawse, J. R., Ames, M. M., Ingle Buhrow, J. N., Safgren, S. L., McGovern, R. M., Black, J., Dockter, T., Haddad, T. C., Erlichman, C., Adjei, A. & 7 others, Collins, D., Streicher, H., Chalmers, Z. R., Frampton, G., Hawse, J. R., Doroshow, J. H. & Collins, J. M., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3391-3400 10 p.

Research output: Contribution to journalArticle

30 Scopus citations

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

Norton, N., Youssef, B., Hillman, D. W., Nassar, A., Geiger, X. J., Necela, B. M., Liu, H., Ruddy, K. J., Polley, M. Y. C., Ingle, J. N., Couch, F. J., Perez, E. A., Liu, M. C., Carter, J. M., Leon-Ferre, R. A., Boughey, J. C., Somers, E. B., Kalari, K. R., Visscher, D. W., Goetz, M. P. & 1 others, Knutson, K. L., Dec 1 2020, In : npj Breast Cancer. 6, 1, 4.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: Results of a multicenter phase II trial

Holtan, S. G., Steen, P. D., Foster, N. R., Erlichman, C., Medeiros, F., Ames, M. M., Safgren, S. L., Graham, D. L., Behrens, R. J. & Goetz, M. P., Jul 17 2012, In : PloS one. 7, 7, e39285.

Research output: Contribution to journalArticle

4 Scopus citations

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

Yoon, H. H., Foster, N. R., Meyers, J. P., Steen, P. D., Visscher, D. W., Pillai, R., Prow, D. M., Reynolds, C. M., Marchello, B. T., Mowat, R. B., Mattar, B. I., Erlichman, C. & Goetz, M. P., Feb 1 2016, In : Annals of Oncology. 27, 2, p. 339-344 6 p., mdv543.

Research output: Contribution to journalArticle

18 Scopus citations

Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy

Ingle, J. N., Xie, F., Ellis, M. J., Goss, P. E., Shepherd, L. E., Chapman, J. A. W., Chen, B. E., Kubo, M., Furukawa, Y., Momozawa, Y., Stearns, V., Pritchard, K. I., Barman, P., Carlson, E. E., Goetz, M. P., Weinshilboum, R. M., Kalari, K. R. & Wang, L., Dec 1 2016, In : Cancer research. 76, 23, p. 7012-7023 12 p.

Research output: Contribution to journalArticle

20 Scopus citations

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

Ingle, J. N., Schaid, D. J., Goss, P. E., Liu, M., Mushiroda, T., Chapman, J. A. W., Kubo, M., Jenkins, G. D., Batzler, A., Shepherd, L., Pater, J., Wang, L., Ellis, M. J., Stearns, V., Rohrer, D. C., Goetz, M. P., Pritchard, K. I., Flockhart, D. A., Nakamura, Y. & Weinshilboum, R. M., Nov 1 2010, In : Journal of Clinical Oncology. 28, 31, p. 4674-4682 9 p.

Research output: Contribution to journalArticle

152 Scopus citations

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

Ingle, J. N., Kalari, K. R., Wickerham, D. L., Von Minckwitz, G., Fasching, P. A., Furukawa, Y., Mushiroda, T., Goetz, M. P., Barman, P., Carlson, E. E., Rastogi, P., Costantino, J. P., Cairns, J., Paik, S., Bear, H. D., Kubo, M., Wang, L. M., Wolmark, N. & Weinshilboum, R. M., Jan 1 2018, In : Pharmacogenetics and Genomics. 28, 6, p. 147-152 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer

Goetz, M. P., Martin, M., Tokunaga, E., Park, I. H., Huober, J., Toi, M., Stoffregen, C., Shekarriz, S., Andre, V., Gainford, M. C., Price, G. L. & Johnston, S., 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
1 Scopus citations

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

Shah, S. S., Ketterling, R. P., Goetz, M. P., Ingle, J. N., Reynolds, C. A., Perez, E. A. & Chen, B., Jan 1 2010, In : Human Pathology. 41, 1, p. 103-106 4 p.

Research output: Contribution to journalArticle

39 Scopus citations

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Leon-Ferre, R. A., Polley, M-Y., Liu, H., Gilbert, J. A., Cafourek, V., Hillman, D. W., Elkhanany, A., Akinhanmi, M., Lilyquist, J., Thomas, A., Negron, V., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K. R., Couch, F. J., Visscher, D. W. & Goetz, M. P., Sep 14 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Inhibition of Cdk2 kinase activity selectively targets the CD44 +/CD24-/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

Opyrchal, M., Salisbury, J. L., Iankov, I., Goetz, M. P., McCubrey, J., Gambino, M. W., Malatino, L., Puccia, G., Ingle, J. N., Galanis, E. & D'Assoro, A. B., Sep 2014, In : International journal of oncology. 45, 3, p. 1193-1199 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Landscape of Neoadjuvant Therapy for Breast Cancer

Haddad, T. C. & Goetz, M. P., May 1 2015, In : Annals of Surgical Oncology. 22, 5, p. 1408-1415 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Loss of heterozygosity at the CYP2D6 locus in breast cancer: Implications for germline pharmacogenetic studies

Goetz, M. P., Sun, J. X., Suman, V. J., Silva, G. O., Perou, C. M., Nakamura, Y., Cox, N. J., Stephens, P. J., Miller, V. A., Ross, J. S., Chen, D., Safgren, S. L., Kuffel, M. J., Ames, M. M., Kalari, K. R., Gomez, H. L., Gonzalez-Angulo, A. M., Burgues, O., Brauch, H. B., Ingle, J. N. & 2 others, Ratain, M. J. & Yelensky, R., Feb 1 2015, In : Journal of the National Cancer Institute. 107, 2, dju401.

Research output: Contribution to journalArticle

34 Scopus citations

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

Rimawi, M. F., de Angelis, C., Contreras, A., Pareja, F., Geyer, F. C., Burke, K. A., Herrera, S., Wang, T., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Chang, J. C., Krop, I. E., Wolff, A. C., Pavlick, A. C., Fuqua, S. A. W., Gutierrez, C., Hilsenbeck, S. G., Li, M. M. & 4 others, Weigelt, B., Reis-Filho, J. S., Kent Osborne, C. & Schiff, R., Nov 7 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-10 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Management of abemaciclib associated adverse events in patients with hormone receptor positive (HR+), HER2- advanced breast cancer: Analysis of the MONARCH trials

Rugo, H. S., Tolaney, S. M., Huober, J., Toi, M., André, V., Barriga, S., Forrester, T., Sledge, G. W. & Goetz, M. P., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii110-viii111

Research output: Contribution to journalArticle

Open Access

Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

Khurana, A., Jung-Beom, D., He, X., Kim, S. H., Busby, R. C., Lorenzon, L., Villa, M., Baldi, A., Molina, J., Goetz, M. P. & Shridhar, V., Apr 1 2013, In : Clinical and Experimental Metastasis. 30, 4, p. 407-415 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

Al-Hilli, Z., Choong, G., Keeney, M. G., Visscher, D. W., Ingle, J. N., Goetz, M. P. & Jakub, J. W., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 709-716 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Molecular analysis of metaplastic breast carcinoma: High EGFR copy number via aneusomy

Gilbert, J. A., Goetz, M. P., Reynolds, C. A., Ingle, J. N., Giordano, K. F., Suman, V. J., Blair, H. E., Jenkins, R. B., Lingle, W. L., Reinholz, M. M., Adjei, A. A. & Ames, M. M., Apr 1 2008, In : Molecular cancer therapeutics. 7, 4, p. 944-951 8 p.

Research output: Contribution to journalArticle

49 Scopus citations

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

Opyrchal, M., Malgorzata, G., Salisbury, J. L., Goetz, M. P., Suman, V., Degnim, A., McCubrey, J., Haddad, T., Iankov, I., Kurokawa, C. B., Shumacher, N., Ingle, J. N., Galanis, E. & D'Assoro, A. B., 2017, In : Oncotarget. 8, 53, p. 91803-91816 14 p.

Research output: Contribution to journalArticle

9 Scopus citations

MONARCH 3: Abemaciclib as initial therapy for advanced breast cancer

Goetz, M. P., Toi, M., Campone, M., Trédan, O., Bourayou, N., Sohn, J., Park, I. H., Paluch-Shimon, S., Huober, J., Chen, S. C., Manso, L., Barriga, S., Freedman, O. C., Jaliffe, G. G., Forrester, T., Frenzel, M., Smith, I. C. & Di Leo, A., Nov 10 2017, In : Journal of Clinical Oncology. 35, 32, p. 3638-3646 9 p.

Research output: Contribution to journalArticle

330 Scopus citations

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Johnston, S., Martin, M., Di Leo, A., Im, S. A., Awada, A., Forrester, T., Frenzel, M., Hardebeck, M. C., Cox, J., Barriga, S., Toi, M., Iwata, H. & Goetz, M. P., Dec 1 2019, In : npj Breast Cancer. 5, 1, 5.

Research output: Contribution to journalArticle

Open Access
42 Scopus citations

Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2–overexpressing breast cancer: TBCRC 006

Rimawi, M. F., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Rodriguez, A. A., Pavlick, A. C., Wang, T., Hilsenbeck, S. G., Gutierrez, C., Schiff, R., Osborne, C. K. & Chang, J. C., May 10 2013, In : Journal of Clinical Oncology. 31, 14, p. 1726-1731 6 p.

Research output: Contribution to journalArticle

169 Scopus citations

NCCN Guidelines® insights breast cancer, version 1.2017: Featured updates to the NCCN Guidelines

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M. P., Goldstein, L. J., Isakoff, S. J., Lyons, J., Kelly Marcom, P., Mayer, I. A., McCormick, B., Moran, M. S., O'Regan, R. M., Patel, S. A. & 13 others, Pierce, L. J., Reed, E. C., Salerno, K. E., Schwartzberg, L. S., Sitapati, A., Smith, K. L., Smith, M. L., Soliman, H., Somlo, G., Telli, M., Ward, J. H., Shead, D. A. & Kumar, R., Apr 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 4, p. 433-451 19 p.

Research output: Contribution to journalArticle

Open Access
173 Scopus citations

NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer

Ma, C. X., Gao, F., Luo, J., Northfelt, D. W., Goetz, M. P., Forero, A., Hoog, J., Naughton, M., Ademuyiwa, F., Suresh, R., Anderson, K. S., Margenthaler, J., Aft, R., Hobday, T. J., Moynihan, T., Gillanders, W., Cyr, A., Eberlein, T. J., Hieken, T. J., Krontiras, H. & 14 others, Guo, Z., Lee, M. V., Spies, N. C., Skidmore, Z. L., Griffith, O. L., Griffith, M., Thomas, S., Bumb, C., Vij, K., Huang Bartlett, C., Koehler, M., Al-Kateb, H., Sanati, S. & Ellis, M. J., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4055-4065 11 p.

Research output: Contribution to journalArticle

96 Scopus citations

Neratinib efficacy and circulating tumor DNA detection of HER2 mutations in HER2 nonamplified metastatic breast cancer

Ma, C. X., Bose, R., Gao, F., Freedman, R. A., Telli, M. L., Kimmick, G., Winer, E., Naughton, M., Goetz, M. P., Russell, C., Tripathy, D., Cobleigh, M., Forero, A., Pluard, T. J., Anders, C., Niravath, P. A., Thomas, S., Anderson, J., Bumb, C., Banks, K. C. & 10 others, Lanman, R. B., Bryce, R., Lalani, A. S., Pfeifer, J., Hayes, D. F., Pegram, M., Blackwell, K., Bedard, P. L., Al-Kateb, H. & Ellis, M. J. C., Oct 1 2017, In : Clinical Cancer Research. 23, 19, p. 5687-5695 9 p.

Research output: Contribution to journalArticle

57 Scopus citations

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma

Mc Williams, R. R., Foster, N. R., Mahoney, M. R., Smyrk, T. C., Murray, J. A., Ames, M. M., Horvath, L. E., Schneider, D. J., Hobday, T. J., Jatoi, A., Meyers, J. P. & Goetz, M. P., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

15 Scopus citations

NOTCH3 expression is linked to breast cancer seeding and distant metastasis

Leontovich, A. A., Jalalirad, M., Salisbury, J. L., Mills, L., Haddox, C., Schroeder, M., Tuma, A., Guicciardi, M. E., Zammataro, L., Gambino, M. W., Amato, A., Di Leonardo, A., McCubrey, J., Lange, C. A., Liu, M., Haddad, T., Goetz, M., Boughey, J., Sarkaria, J., Wang, L. & 3 others, Ingle, J. N., Galanis, E. & D'Assoro, A. B., Sep 4 2018, In : Breast Cancer Research. 20, 1, 105.

Research output: Contribution to journalArticle

12 Scopus citations

Once-daily radiation therapy for inflammatory breast cancer

Brown, L., Harmsen, W., Blanchard, M., Goetz, M., Jakub, J., Mutter, R., Petersen, I., Rooney, J., Stauder, M., Yan, E. & Laack, N., Aug 1 2014, In : International Journal of Radiation Oncology Biology Physics. 89, 5, p. 997-1003 7 p.

Research output: Contribution to journalArticle

12 Scopus citations

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

Hawse, J. R., Carter, J. M., Aspros, K. G. M., Bruinsma, E. S., Koepplin, J. W., Negron, V., Subramaniam, M., Ingle, J. N., Rech, K. L. & Goetz, M. P., Jan 1 2020, In : Breast Cancer Research and Treatment. 179, 1, p. 241-249 9 p.

Research output: Contribution to journalArticle

Oxaliplatin plus oral fluoropyrimidines in colorectal cancer

Grothey, A. & Goetz, M. P., Jun 2004, In : Clinical colorectal cancer. 4, SUPPL. 1, p. S37-S42

Research output: Contribution to journalArticle

14 Scopus citations

Painful metastases involving bone: Feasibility of percutaneous CT- and US-guided radio-frequency ablation

Callstrom, M. R., Charboneau, J. W., Goetz, M. P., Rubin, J., Wong, G. Y., Sloan, J. A., Novotny, P. J., Lewis, B. D., Welch, T. J., Farrell, M. A., Maus, T. P., Lee, R. A., Reading, C. C., Petersen, I. A. & Pickett, D. D., Jan 1 2002, In : Radiology. 224, 1, p. 87-97 11 p.

Research output: Contribution to journalArticle

235 Scopus citations

Painful metastasis involving bone: Percutaneous image-guided cryoablation - Prospective trial interim analysis

Callstrom, M. R., Atwell, T. D., Charboneau, J. W., Farrell, M. A., Goetz, M. P., Rubin, J., Sloan, J. A., Novotny, P. J., Welch, T. J., Maus, T. P., Wong, G. Y. & Brown, K. J., Nov 1 2006, In : Radiology. 241, 2, p. 572-580 9 p.

Research output: Contribution to journalArticle

161 Scopus citations
86 Scopus citations

PANOPLY: Omics-guided drug prioritization method tailored to an individual patient

Kalari, K. R., Sinnwell, J. P., Thompson, K. J., Tang, X., Carlson, E. E., Yu, J., Vedell, P. T., Ingle, J. N., Weinshilboum, R. M., Boughey, J. C., Wang, L., Goetz, M. P. & Suman, V., Jan 1 2018, In : JCO Clinical Cancer Informatics. 2018, 2, p. 1-12 12 p.

Research output: Contribution to journalArticle

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Wagner, L. I., Gray, R. J., Sparano, J. A., Whelan, T. J., Garcia, S. F., Yanez, B., Tevaarwerk, A. J., Carlos, R. C., Albain, K. S., Olson, J. A., Goetz, M. P., Pritchard, K. I., Hayes, D. F., Geyer, C. E., Dees, E. C., McCaskill-Stevens, W. J., Minasian, L. M., Sledge, G. W. & Cella, D., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1875-1886 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

Loibl, S., Metzger, O., Mandrekar, S. J., Mundhenke, C., Seiler, S., Valagussa, P., DeMichele, A., Lim, E., Tripathy, D., Winer, E. P., Huang, C., Carey, L., Francis, P., Miller, K. D., Goetz, M. P., Prat, A., Loi, S., Krop, I., Gianni, L. & Ciruelos, E. M., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii121

Research output: Contribution to journalArticle

Open Access

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248

Alberts, S. R., Kim, G. P., Mahoney, M. R., Gornet, M. K., Rubin, J., Ames, M., Goetz, M. P., Weinshilboum, R. M., Nicol, S. J. & Goldberg, R. M., Jul 2007, In : Clinical colorectal cancer. 6, 8, p. 572-577 6 p.

Research output: Contribution to journalArticle

1 Scopus citations